If you are wondering about taking orlistat and Mounjaro together, here is the important starting point: there is no established clinical evidence showing that this combination is safe or more effective, and using both together is not part of the licensed use of either medicine. This does not mean that a dangerous interaction has been identified. It means that the specific combination has not been properly studied, so there is limited evidence to guide this decision.
For adults in the UK who are using, considering, or have been prescribed weight loss medication, this distinction matters. Taking both medicines could mean dealing with side effects from two treatments at the same time, while the extra benefit is uncertain. It can also make it harder to work out which medicine is causing a particular side effect.
This guide explains what is known about orlistat and Mounjaro separately, how they work, how their side effects differ, what clinical evidence shows about weight loss, what to consider when switching treatments, and what to discuss with a prescriber before taking both.
Key things to know
- There is no established clinical trial evidence confirming the safety or effectiveness of taking orlistat and Mounjaro together, and the combination is not part of the licensed use of either medicine
- This does not mean a dangerous interaction has been identified. It means there is limited evidence about the specific combination
- Taking both could mean dealing with gastrointestinal side effects from two medicines at the same time
- Comparing orlistat with Mounjaro is a different question from deciding whether to take them together
- A prescriber should assess your individual circumstances before you combine, stop, or switch weight loss medicines
Why "Never Studied Together" Matters
It is important to be precise here. There is no established clinical trial evidence showing what happens when orlistat and tirzepatide, the active ingredient in Mounjaro, are used together for weight management.
That does not mean the medicines have a known dangerous interaction. It means the specific question of whether the combination is safe, well tolerated, or more effective has not been properly answered by clinical research.
This is different from saying that two medicines have been studied together and found to be safe. When there is no combination data, a prescriber has to consider the known effects, side effects, and interactions of each medicine separately before deciding whether using both is appropriate.
For that reason, it is better not to assume that combining two weight loss medicines will automatically lead to greater weight loss. There is no established evidence to support that conclusion for orlistat and Mounjaro together.
Where Each One Actually Acts: Fat Absorption and Beyond
Orlistat and Mounjaro work in different ways.
Orlistat works mainly in the digestive system. It reduces the amount of dietary fat that your body absorbs by blocking some of the enzymes needed to digest fat. This means some of the fat from your food passes through the digestive system without being absorbed.
Orlistat does not work by directly reducing appetite. It can still contribute to weight loss when used alongside a reduced calorie diet.
Mounjaro contains tirzepatide, which acts on GLP 1 and glucose dependent insulinotropic polypeptide receptors. It can affect appetite, food intake, blood sugar regulation, and the rate at which food leaves the stomach.
Because the medicines work differently, it may seem logical that combining them would provide an additional effect. However, different mechanisms do not automatically mean that combining treatments provides extra benefit. There is not enough clinical evidence to confirm that taking orlistat and Mounjaro together improves weight loss.
Orlistat has limited absorption into the bloodstream, but this does not provide evidence that the combination with Mounjaro is safe or useful for everyone.
Compare or Combine? Two Different Questions
| What you are asking | The honest answer |
|---|---|
| How does orlistat compare to Mounjaro? | This can be a useful comparison. They work differently and clinical trials have reported different average weight loss results. |
| Should I take them together? | This combination has not been properly studied for weight management. A prescriber should assess whether there is a clinical reason to use both. |
The Genuine Practical Problem: Stacked Side Effects
Orlistat can cause gastrointestinal side effects such as oily or fatty stools, increased bowel movements, flatulence, and an urgent need to use the toilet. These effects can be more noticeable after meals that are high in fat.
Mounjaro can also cause gastrointestinal side effects, including nausea, diarrhoea, constipation, vomiting, and abdominal discomfort.
Taking both medicines could therefore make digestive symptoms more difficult to manage. If you develop diarrhoea, stomach discomfort, nausea, or changes in your bowel movements, it may also be harder to work out which medicine is responsible.
That matters because the way a side effect is managed can depend on the medicine causing it. Orlistat related bowel changes may be linked to the amount of fat in your diet, while Mounjaro related gastrointestinal symptoms can be associated with the medicine itself and may be more noticeable during dose increases.
Taking medicines that can cause vomiting or diarrhoea may also increase the risk of dehydration if these symptoms are severe or persistent. If you have ongoing vomiting or diarrhoea, cannot keep fluids down, or feel significantly unwell, speak to a healthcare professional promptly.
Does Combining Them Add Real Value?
There is no established evidence that taking orlistat and Mounjaro together provides additional weight loss compared with using either treatment appropriately on its own.
Orlistat works on dietary fat. Mounjaro can reduce appetite and food intake. If Mounjaro has already changed how much and what you eat, the amount of dietary fat being consumed may also change. This does not mean that orlistat would have no effect, but its additional benefit when used with Mounjaro has not been established.
There is also a cost and convenience question. Paying for two ongoing treatments may not be worthwhile if there is no clear clinical reason to use both.
Your prescriber may instead review how you are responding to your current treatment, whether your dose is appropriate, whether side effects are manageable, and whether another treatment would be more suitable.
More medication does not automatically mean more weight loss. The aim should be to use a treatment plan that is appropriate for your health, effective enough for your circumstances, and manageable over time.
Orlistat vs Mounjaro: A Fair Comparison of Weight Loss Medications
Clinical trials have generally reported greater average weight loss with tirzepatide than with orlistat. However, the medicines have been studied in different clinical settings and populations, so their trial results should not be treated as a direct head to head comparison.
In a 72 week trial of tirzepatide for weight management, people taking the highest studied dose had an average body weight reduction of around 20.9%, with some trial results reporting reductions of around 22.5% depending on the analysis and study population.
Orlistat generally produces more modest average weight loss. Clinical guidance and trial data commonly report around 3% to 5% additional weight loss compared with diet and lifestyle measures alone.
These figures describe average results from clinical studies. They do not predict how much weight one particular person will lose.
Orlistat can still be a suitable option for some people. It is an oral medicine and has a different side effect profile from Mounjaro. Some people may also prefer a tablet rather than a weekly injection.
The right choice depends on factors such as your health, weight, other medicines, treatment goals, side effects, and what type of treatment you can use safely and consistently.
The 12 Week Orlistat Review Point
Orlistat treatment is usually reviewed after around 12 weeks. Whether treatment should continue can depend on how much weight you have lost from your starting weight and whether the medicine is considered suitable for you.
Orlistat is intended to be used alongside a reduced calorie diet. The medicine works by reducing the amount of dietary fat that is absorbed, so following the recommended diet is an important part of treatment.
Some guidance describes orlistat as potentially increasing weight loss compared with diet alone. The amount of additional weight loss varies between people and should not be treated as a guarantee.
The 12 week review can also be a useful opportunity to discuss your treatment if you are not seeing the progress you expected or if side effects are difficult to manage. Your prescriber can then consider whether continuing orlistat, changing treatment, or exploring another option such as Mounjaro is appropriate.
Switching From Orlistat to Mounjaro
If you are considering switching from orlistat to Mounjaro rather than taking both, speak to your prescriber before making the change.
There is no need to assume that you should combine the two medicines during a switch. Your prescriber can advise you on how to stop orlistat and when to start Mounjaro based on your individual circumstances.
Mounjaro is normally started at 2.5mg once a week when beginning treatment, followed by dose increases at intervals recommended in the product information and by your prescriber. Your previous use of orlistat does not mean you should start Mounjaro at a higher dose.
It is also useful to tell your prescriber what happened while you were taking orlistat. For example, explain how much weight you lost, whether your weight changed after the first few months, and whether side effects affected your ability to continue treatment.
Orlistat can reduce the absorption of some fat soluble vitamins, so some people taking it may be advised to use a vitamin supplement. If you have been taking supplements because of orlistat, tell your prescriber or pharmacist before stopping or changing treatment. They can advise whether you still need them.
Being specific about your experience can make the consultation more useful. Instead of simply saying that orlistat did not work, you could explain that you lost some weight initially but then stopped losing weight, or that the bowel related side effects became difficult to manage.
If you are weighing up your options, Mounjaro treatment and orlistat are both available through our weight loss treatments. A clinical consultation can help you understand which option may be appropriate for your circumstances.
If you have concerns about unexpected, significant, or rapid weight loss, speak to your prescriber before changing or combining your medicines.
Genuine Orlistat Pricing
| Product | 4 week supply | With code EDM10 |
|---|---|---|
| Generic orlistat 120mg | £32.99 | £29.69 |
| Xenical 120mg | £42.99 | £38.69 |
| Alli 60mg | £28.99 | £26.09 |
Prices can change, and promotional codes may have terms and conditions. Check the current price before ordering.
Sources
- NHS: Orlistat, who cannot take it and interactions (nhs.uk/medicines/orlistat)
- Mounjaro (tirzepatide) prescribing information, Eli Lilly and Company
- NICE guidance on orlistat for weight management
Medical Disclaimer
This page provides general information about orlistat and Mounjaro. It is not a substitute for personalised medical advice, diagnosis, or treatment.
There is no established clinical evidence confirming the safety or effectiveness of taking orlistat and Mounjaro together for weight management, and the combination is not part of the licensed use of either medicine. Whether either medicine is appropriate for you should be assessed by a qualified prescriber based on your medical history, current medicines, health conditions, and treatment needs.
Weight loss figures included on this page are based on clinical trial data and describe average results. They do not predict individual results or guarantee a particular amount of weight loss.
If you are considering starting, stopping, switching, or combining weight loss medicines, speak to your prescriber, pharmacist, or GP for advice based on your circumstances.
